SARS-CoV-2 causes an additional burden of acute respiratory illnesses in the season 2022/2023

Last spring 2023, as part of our survey on acute respiratory diseases, we asked participants about the cold season in autumn/winter 2022/2023. 37,708 DigiHero participants reported a total of 54,813 acute respiratory illnesses. For 79% of these diseases, we were also provided with the results of a SARS-CoV-2 test. This allowed us to identify 9,358 infections as COVID-19 diseases. This means that 25% of DigiHero participants were infected with SARS-CoV-2 during the winter of 2022/2023. Figure A shows the monthly new infections we calculated for acute respiratory diseases with and without a positive test for SARS-CoV-2. An analysis by age group showed that young DigiHero participants in particular became infected with acute respiratory diseases (see Figure B).

Figure A and B: Number of new infections of acute respiratory diseases with and without a positive SARS-CoV-2 test in the season 2022/2023, A) per month, B) per age group. (translated version, original https://doi.org/10.1016/j.ijid.2024.107057, Creative Commons Licence https://creativecommons.org/licenses/by-nc-nd/4.0/)

The World Health Organization declared the COVID-19 pandemic to be over in May 2023, but SARS-CoV-2 gradually developed into a seasonal pathogen, similar to the flu. Our data shows that SARS-CoV-2 caused 21% additional acute respiratory illnesses. Extrapolated to the adult population of Germany, this would mean at least 17 million additional infections during the cold season. An analysis of infection data from the Robert Koch Institute’s GrippeWeb portal provided similar results. For autumn/winter 2022/2023, there was an increase in acute respiratory diseases of almost 20 million compared to cold seasons in years before the COVID-19 pandemic.
 
Our data was published in an English-language scientific journal and can be viewed using the following link: